The Traditional Japanese Formula Keishibukuryogan Inhibits the Production of Inflammatory Cytokines by Dermal Endothelial Cells
2010

Keishibukuryogan Reduces Inflammation in Skin Cells

Sample size: 5 publication Evidence: moderate

Author Information

Author(s): Yoshihisa Yoko, Furuichi Megumi, Ur Rehman Mati, Ueda Chieko, Makino Teruhiko, Shimizu Tadamichi

Primary Institution: University of Toyama

Hypothesis

Does Keishibukuryogan inhibit the production of inflammatory cytokines in human dermal endothelial cells?

Conclusion

Keishibukuryogan significantly suppresses the production of inflammatory cytokines in LPS-stimulated human dermal endothelial cells.

Supporting Evidence

  • KBG treatment significantly suppressed mRNA levels of inflammatory cytokines.
  • Paeoniflorin also inhibited the production of inflammatory cytokines.
  • KBG and paeoniflorin decreased the expression of COX-2 and iNOS.

Takeaway

Keishibukuryogan, a traditional Japanese medicine, helps reduce inflammation in skin cells, which could be good for treating certain skin diseases.

Methodology

The study used human dermal microvessel endothelial cells treated with lipopolysaccharide and either Keishibukuryogan or paeoniflorin to measure cytokine production.

Statistical Information

P-Value

<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1155/2010/804298

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication